CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 102,281	$ 134,710
Accounts receivable, net	212,755	259,637
Inventory, net	99,406	86,502
Other current assets and prepaid expenses	23,274	27,170
Assets held for sale	316,353	314,994
Total current assets	754,069	823,013
Property, plant and equipment, net	81,899	79,727
Intangible assets, net	890,498	321,683
In-process research and development	0	590,200
Goodwill	519,052	520,601
Investments	9,472	10,729
Operating lease right-of-use assets	42,768	44,228
Other assets	9,100	9,534
Total assets	2,306,858	2,399,715
Current liabilities:
Accounts payable	94,240	82,040
Accrued expenses	157,316	193,493
Current maturities of operating leases	11,690	11,624
Liabilities associated with assets held-for-sale	28,512	28,156
Current portion of lines of credit and notes payable	17,412	14,695
Total current liabilities	309,170	330,008
Operating lease liabilities	31,596	33,097
Convertible notes	210,520	187,935
Deferred tax liabilities	125,030	148,487
Other long-term liabilities, principally contract liabilities, contingent consideration and lines of credit	15,658	15,062
Total long-term liabilities	382,804	384,581
Total liabilities	691,974	714,589
Equity:
Common Stock - $0.01 par value, 1,000,000,000 shares authorized; 690,138,033 and 690,082,283 shares issued at March 31, 2022 and December 31, 2021, respectively	6,902	6,901
Treasury Stock - 8,655,082 and 8,655,082 shares at March 31, 2022 and December 31, 2021, respectively	(1,791)	(1,791)
Additional paid-in capital	3,191,139	3,222,487
Accumulated other comprehensive loss	(31,415)	(30,495)
Accumulated deficit	(1,549,951)	(1,511,976)
Total shareholders’ equity	1,614,884	1,685,126
Total liabilities and equity	$ 2,306,858	$ 2,399,715